Biotage AB (BIOT) - Total Assets

Latest as of March 2025: Skr4.71 Billion SEK ≈ $506.66 Million USD

Based on the latest financial reports, Biotage AB (BIOT) holds total assets worth Skr4.71 Billion SEK (≈ $506.66 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Biotage AB - Total Assets Trend (2000–2024)

This chart illustrates how Biotage AB's total assets have evolved over time, based on quarterly financial data. Also see Biotage AB (BIOT) total market value for the company's overall valuation and market capitalisation.

Biotage AB - Asset Composition Analysis

Current Asset Composition (December 2024)

Biotage AB's total assets of Skr4.71 Billion consist of 26.6% current assets and 73.4% non-current assets. Review Biotage AB balance sheet liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr434.00 Million	8.5%
Accounts Receivable	Skr382.00 Million	7.5%
Inventory	Skr458.00 Million	9.0%
Property, Plant & Equipment	Skr330.00 Million	6.5%
Intangible Assets	Skr765.00 Million	15.0%
Goodwill	Skr2.56 Billion	50.2%

Asset Composition Trend (2000–2024)

This chart illustrates how Biotage AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See BIOT live share price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Biotage AB's current assets represent 26.6% of total assets in 2024, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 8.5% of total assets in 2024, up from 2.1% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 64.0% of total assets, an increase from 1.0% in 2000.
Asset Diversification: The largest asset category is goodwill at 50.2% of total assets.

Biotage AB Competitors by Total Assets

Key competitors of Biotage AB based on total assets are shown below.

Company	Country	Total Assets
Gan & Lee Pharmaceuticals Co Ltd SHG:603087	China	CN¥12.68 Billion
Andon Health Co Ltd SHE:002432	China	CN¥29.91 Billion
Shenyang Xingqi Pharmaceutical Co Ltd SHE:300573	China	CN¥2.42 Billion
Pegavision TW:6491	Taiwan	NT$16.17 Billion
Nanosonics Ltd AU:NAN	Australia	AU$279.25 Million
Visco Vision Inc. TW:6782	Taiwan	NT$5.82 Billion
QITIAN Technology Group Co Ltd SHE:300061	China	CN¥1.17 Billion
Embecta Corp NASDAQ:EMBC	USA	$1.27 Billion

Biotage AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.53	2.16	3.46
Quick Ratio	1.61	1.52	2.51
Cash Ratio	0.88	0.00	0.00
Working Capital	Skr729.00 Million	Skr799.00 Million	Skr458.08 Million

Biotage AB - Advanced Valuation Insights

This section examines the relationship between Biotage AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.98
Latest Market Cap to Assets Ratio	0.24
Asset Growth Rate (YoY)	3.5%
Total Assets	Skr5.10 Billion
Market Capitalization	$1.23 Billion USD

Valuation Analysis

Below Book Valuation: The market values Biotage AB's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Biotage AB's assets grew by 3.5% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Biotage AB (2000–2024)

The table below shows the annual total assets of Biotage AB from 2000 to 2024.

Year	Total Assets	Change
2024-12-31	Skr5.10 Billion ≈ $549.27 Million	+3.51%
2023-12-31	Skr4.93 Billion ≈ $530.65 Million	+110.82%
2022-12-31	Skr2.34 Billion ≈ $251.71 Million	+17.42%
2021-12-31	Skr1.99 Billion ≈ $214.37 Million	+38.87%
2020-12-31	Skr1.43 Billion ≈ $154.37 Million	+7.39%
2019-12-31	Skr1.34 Billion ≈ $143.74 Million	+33.14%
2018-12-31	Skr1.00 Billion ≈ $107.96 Million	+32.49%
2017-12-31	Skr757.20 Million ≈ $81.49 Million	+8.92%
2016-12-31	Skr695.20 Million ≈ $74.81 Million	+3.94%
2015-12-31	Skr668.83 Million ≈ $71.98 Million	+8.05%
2014-12-31	Skr619.01 Million ≈ $66.62 Million	+4.52%
2013-12-31	Skr592.25 Million ≈ $63.74 Million	-9.45%
2012-12-31	Skr654.07 Million ≈ $70.39 Million	-6.43%
2011-12-31	Skr699.05 Million ≈ $75.23 Million	+0.81%
2010-12-31	Skr693.43 Million ≈ $74.62 Million	-43.50%
2009-12-31	Skr1.23 Billion ≈ $132.09 Million	-5.51%
2008-12-31	Skr1.30 Billion ≈ $139.79 Million	+31.40%
2007-12-31	Skr988.60 Million ≈ $106.39 Million	+7.78%
2006-12-31	Skr917.26 Million ≈ $98.71 Million	-5.90%
2005-12-31	Skr974.74 Million ≈ $104.90 Million	+40.22%
2004-12-31	Skr695.15 Million ≈ $74.81 Million	-15.91%
2003-12-31	Skr826.65 Million ≈ $88.96 Million	+21.92%
2002-12-31	Skr678.04 Million ≈ $72.97 Million	-19.93%
2001-12-31	Skr846.82 Million ≈ $91.13 Million	-11.19%
2000-12-31	Skr953.47 Million ≈ $102.61 Million	--

About Biotage AB

ST:BIOT Sweden Medical Instruments & Supplies

Market Cap

$1.23 Billion

Skr11.46 Billion SEK

Market Cap Rank

#7993 Global

#122 in Sweden

Share Price

Skr143.20

Change (1 day)

+0.00%

52-Week Range

Skr143.20 - Skr143.20

All Time High

Skr280.87